Zenas BioPharma, Inc (NASDAQ:ZBIO) IPO will take place September, 13 on the NASDAQ exchange under the ticker ZBIO.

The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 12, 2025.

See also: Benzinga IPO Calendar

About Zenas BioPharma, Inc

Zenas BioPharma, Inc is a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.